Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Tobi Thomas

Drug that could slow womb cancer to be rolled out by NHS in England

Illustration depicting red cancerous cells spreading in a female body attacking the womb and reproductive system anatomy including ovaries and fallopian tubes, depicted in blue
There are 9,700 new cases and 2,400 deaths due to womb-related cancers each year across the UK, according to Cancer Research. Illustration: Brain light/Alamy

A drug that could improve the quality of life of hundreds of women with womb cancer will be rolled out on the NHS across England from Tuesday.

Dostarlimab, also known as Jemperli, is an immunotherapy that works by attracting specific proteins on the surface of cancer cells to help the immune system attack them.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.